Standard Diagnostics Of S. Korea Target Of $286 Million Stock Buy
This article was originally published in PharmAsia News
Executive Summary
South Korea's Standard Diagnostics has been offered $286 million for a majority stake by U.S. device maker Inverness Medical Innovations